Hide filtersShow filters × Close Bryan, Garnier & Co acts as Joint Bookrunner on Faron Pharmaceuticals’ EUR 12 million Follow-On Offering Bryan, Garnier & Co acts as Sole Financial Advisor to Emeria on the contemplated sale of Seiitra, leading software provider dedicated to real estate professionals, to Orisha Bryan, Garnier & Co acts as the Sole Financial Advisor to Orbex and its shareholders in connection with the first close of the Series D fundraising, led by the UK Department for Science, Innovation and Technology (DSIT) Bryan, Garnier & Co acts as Sole Financial Advisor on Median Technologies’ EUR 10 million Bridge Financing Bryan, Garnier & Co acts as Sole Financial Advisor to Collaboration Factory AG (cplace) on its sale to Level Equity Bryan, Garnier & Co acts as Sole Financial Advisor to the shareholders of hsbcad BV (“hsbcad”), a leading software solution provider for offsite timber construction, on its contemplated acquisition to Maguar Capital Bryan, Garnier & Co acts as Sole Financial Advisor to Kaïbee, a specialist in Technology consulting, digital solutions development and DevOps, on the sale of the company to Objectware Bryan, Garnier & Co acts as Joint Global Coordinator and Joint Bookrunner to Avantium, a leading renewable and circular plastics company, on a EUR 11.2m ABB Bryan, Garnier & Co acts as Sole Financial Advisor to Sobro and its co-shareholders in the sale of Dafo Vehicle to United Safety & Survivability Corporation Bryan, Garnier & Co acts as Sole Financial Advisor, Joint Global Coordinator & Joint Bookrunner on Exact Therapeutics’ NOK 145m Follow-On Offering anchored for USD 7m by GE Healthcare Bryan, Garnier & Co acts as Sole Financial Advisor to Cathay Capital & Wedia’s management team in the public tender offer for Wedia Bryan, Garnier & Co acts as Sole Financial Advisor to the shareholders of 9Solutions on its sale to ASSA ABLOY
